Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roggensack

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Dental Materials : Official Publication of the Academy of Dental Materials|March 1, 1993
Studies on laser- and plasma-welded titaniumM Roggensack, M H Walter, K W Böning
Hypertension (Dallas, Tex. : 1979)|February 4, 1999
Evidence for peroxynitrite formation in the vasculature of women with preeclampsiaA M Roggensack, Y Zhang, S T Davidge
Clinical and Experimental Immunology|August 11, 1998
Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigensA D Kelleher, M Roggensack, S Emery, et al.
AIDS Research and Human Retroviruses|February 14, 1998
Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study GroupL J Ashton, A Carr, P H Cunningham, et al.
AIDS (London, England)|February 19, 1998
Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network InvestigatorsA D Kelleher, M Roggensack, A B Jaramillo, et al.
Placenta|January 24, 2012
A distinct microvascular endothelial gene expression profile in severe IUGR placentasC E Dunk, A M Roggensack, B Cox, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injectionA D Kelleher, S Emery, P Cunningham, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Dental Materials : Official Publication of the Academy of Dental Materials|March 1, 1993
Studies on laser- and plasma-welded titaniumM Roggensack, M H Walter, K W Böning
Hypertension (Dallas, Tex. : 1979)|February 4, 1999
Evidence for peroxynitrite formation in the vasculature of women with preeclampsiaA M Roggensack, Y Zhang, S T Davidge
Clinical and Experimental Immunology|August 11, 1998
Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigensA D Kelleher, M Roggensack, S Emery, et al.
AIDS Research and Human Retroviruses|February 14, 1998
Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study GroupL J Ashton, A Carr, P H Cunningham, et al.
AIDS (London, England)|February 19, 1998
Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network InvestigatorsA D Kelleher, M Roggensack, A B Jaramillo, et al.
Placenta|January 24, 2012
A distinct microvascular endothelial gene expression profile in severe IUGR placentasC E Dunk, A M Roggensack, B Cox, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injectionA D Kelleher, S Emery, P Cunningham, et al.
Pageof 1